Novadip Biosciences – Belgische ‘biotechplasticine’ redt been vijfjarige

Post by: Geert in News article Novadip
  Novadip Press Article: Belgische…
read more
04 Oct 2019
0

Novadip Biosciences Presents Clinical Case Study on Next Generation Tissue Regeneration Therapy for Critical Size Bone Reconstruction at EORS Conference

Post by: Geert in Novadip Press Release
Novadip Biosciences Presents Clinical Case…
read more
02 Oct 2019
0

FierceBiotech names Confo Therapeutics as one of its “Fierce 15” Biotech Companies of 2019

Post by: Geert in Confo Therapeutics Press Release
FierceBiotech names Confo Therapeutics as…
read more
23 Sep 2019
0

Immunic, Inc. Doses First Healthy Volunteer in its Phase 1 Clinical Program of IMU-935, a Potentially Best-in-Class RORgt Inverse Agonist

Post by: Geert in Immunic Press Release
Immunic, Inc. Doses First Healthy…
read more
18 Sep 2019
0

Immunic, Inc.’s Interim Dosing Analysis of IMU-838 as Part of its Ongoing Phase 2 CALDOSE-1 Study in Patients with Moderate-to-Severe Ulcerative Colitis Establishes Broad, Potentially Safe and Effective Dose Range

Post by: Geert in Immunic Press Release
Immunic, Inc.'s Interim Dosing Analysis…
read more
10 Sep 2019
0